Two Presentations at ASH 2025 to highlight preclinical data and clinical development plans for GB3226, a novel dual ENL-YEATS and FLT3 inhibitor ...
Recordati Rare Diseases Inc. today announced the presentation of new data related to its growing portfolio of treatments for rare hematologic disorders at the 67th American Society of Hematology (ASH) ...
1. Naturally, there’s a strong learning component. The stated aim of this type of showcase is for all attendees to learn ...
New York City has its fair share of high-profile restaurants, but dodge the lines and visit these hidden restaurants for a ...
When Connor Fitzgerald sits down to create a lesson plan for his high school English class, he goes about it a little ...
Duchenne (SGT-003): 23 participants have been dosed in the INSPIRE DUCHENNE trial as of October 31, 2025; Solid expects to ...
The 54th International Symposium on High Performance Liquid Phase Separations and Related Techniques (HPLC 2025), was held from June 15–19, 2025, in Bruges, Belgium. This “Column Watch” installment ...
Additionally, USGBC has released updated LEED v5 crosswalks to help streamline the process for projects pursuing multiple ...
Reclassified disease response criteria at 28 days of treatment for acute graft-vs-host disease (GVHD) improved prediction of 6-month nonrelapse mortality (NRM) compared with conventional criteria in ...
The last five years have been defined by tumults and transitions. We have witnessed these at the global, national and industry levels.
This week there is lots to do in the area. Attend a play, a concert, a lecture, a WWI traveling exhibit, a night of gaming or ...
Sibling entrepreneurs displayed their products Saturday at the Eastwood Mall Center Court as part of Junior Achievement of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback